Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

Reporting to the Regional Business Director, the Oncology Account Manager (OAM) will contribute to Kura’s overall sales objective by performing assigned sales related activities. The OAM will provide physicians, pharmacists, nurses and all healthcare professionals (HCPs) with product, services and approved information that will enable the HCPs to appropriately prescribe Kura’s product(s)The OAM will compliantly and successfully implement Kura’s marketing strategies and corresponding tactics in order to achieve short-term and long-term objectives. The ideal candidate will be capable of managing the territory and administrative requirements in an efficient and effective manner and will achieve full compliance with drug laws and regulations when representing Kura and Kura’s products to Healthcare Providers.

ESSENTIAL JOB FUNCTIONS:

Achieve the assigned sales objective for the territory
Attain the designated goals for calls on appropriate healthcare professionals to communicate balanced, accurate, and complete information on Kura’s FDA approved products
Develops and implements a territory business plan to meet customer needs and achieve goals
Navigate through complex external/customer organizational structures including hospitals, IDNs, GPOs and healthcare communities while aligning with cross-functional commercial partners
Demonstrate completion of administrative requirements including budget management, expense reports management, CRM call reporting and synchronization, etc. within timelines and company guidelines
Demonstrates a deep understanding of healthcare professionals (HCP) and account needs, effectively utilizing this knowledge to strategically promote and expand the use of assigned products
Operate the territory within the assigned expense budget and demonstrates fiscal responsibility
Comply with all federal/state/local laws, regulations and guidelines including but not limited to the PhRMA Code on Interactions with Healthcare Professionals as well as complying with all Kura standards and policies relating to all job activities
Successful completion and ongoing updates of all aspects of training including but not limited to product knowledge, disease state, market, selling skills and compliance
Assists in the identification and resolution of issues and opportunities while communicating proactively to marketing and sales management
Develops and consistently demonstrates an expert understanding of HCP and Account needs to appropriately expand use of assigned product.

JOB SPECIFICATIONS:

Undergraduate degree required, ideally in business/marketing/healthcare/life science areas of concentration
6+ years of successful pharmaceutical/biotech sales experience with 3+ in the oncology/hematology and/or rare disease markets, preferably with oral therapeutic selling experience
Management of large territories that includes periodic overnight travel
Occasionally work evenings and weekends as needed for conferences
Excellent written and oral communication skills
Strong computer skills, notably WORD, EXCEL and POWER POINT

The base range for this role is $205,000 to $230,000 per year with a target IC of 60k. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

Kura’s Values that are used for candidate selection and performance assessments:

We work as one for patients
We are goal-focused and deliver with excellence
We are science-driven courageous innovators
We strive to bring out the best in each other and ourselves

The Kura Package

Career advancement/ development opportunities
Competitive comp package
Bonus
401K + Employer contributions
Generous stock options
ESPP Plan
20 days of PTO to start
18 Holidays (Including Summer & Winter Break)
Generous Benefits Package with a variety of plans available with a substantial employer match
Paid Paternity/Maternity Leave
In-Office Catered lunches
Home Office Setup
Lifestyle Spending Stipend
Commuter Stipend (Boston Office)
Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company’s diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology’s approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.

Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R/R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.

Oncology Account Manager

Kura Oncology

Compensation Overview

Simplify's Take

What believers are saying

What critics are saying

What makes Kura Oncology unique

Benefits

Growth & Insights and Company News

6 month growth

1 year growth

2 year growth